The question put before the committee for a vote was whether to move to one COVID-19 vaccine ... If the FDA panel’s ...

The FDA’s expert panel on vaccines voted Thursday to recommend that anyone who gets a primary Covid vaccine going forward ...

The Food and Drug Administration’s independent vaccine advisory committee voted unanimously in favor of having all COVID-19 ...

The FDA says COVID variants continue to evolve, and vaccines’ immunity can wane over time, presenting a continued need for ...

Dr. Kristin Moffitt, an infectious disease specialist at Boston Children's Hospital talks about concerns about COVID vaccines ...

But the FDA believes the time is right for annual shots targeting the latest COVID-19 variants, even though Peter Marks, M.D.

The FDA's advisory committee approved a proposal to phase out the Pfizer and Moderna COVID-19 vaccines used in the original ...

Currently, Pfizer's and Moderna's omicron shots are authorized as a booster, while the first two doses are still the old shots based on the original strain.

In a document posted ahead of an advisory group meeting on Jan 26, the US Food and Drug Administration (FDA) today spelled ...

The CDC and FDA announced on Friday that their surveillance system flagged a possible link between the new Pfizer-BioNTech bivalent Covid-19 vaccine and strokes in people aged 65 and over ...

The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet Thursday to discuss how to simplify ...

bivalent shot and both the CDC and FDA continue to recommend that everyone aged 6 months and older stay up-to-date with their COVID-19 vaccination. Reporting by Bhanvi Satija in Bengaluru ...